Breast cancer models: Is merging human and animal models the future?

Jong B. Kim, Michael J. O'Hare, Robert Stein

Research output: Contribution to journalArticle

63 Citations (Scopus)


Survival rates of patients with early breast cancer in the United Kingdom and in the United States have improved steadily over the past 15 years. The only way to continue or even accelerate this progress, however, is the discovery and development of new preventative and therapeutic strategies. With the massive explosion in potential therapeutic strategies becoming available, in the postgenomic era, better and more representative breast cancer models are urgently required for preclinical trials. Development of better in vivo models of human breast cancer are thus of crucial importance in the development of new cancer therapeutics.
Original languageEnglish
Article number22
JournalBreast Cancer Research
Publication statusPublished - 19 Aug 2003

Cite this